By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
TrovaGene, Inc. To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/7/2014 8:27:40 AM
Clinical Performance of TrovaGene, Inc.'s Precision Cancer Monitoring Platform Presented At Second Annual International ECD Medical Symposium 10/1/2014 9:01:36 AM
TrovaGene, Inc. Expands Clinical Program With New Study Evaluating Its Precision Cancer Monitoring Platform In Lung Cancer 9/29/2014 9:47:40 AM
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins TrovaGene, Inc.'s Scientific Advisory Board 9/17/2014 8:55:54 AM
TrovaGene, Inc. Release: Highly Sensitive And Quantitative Analytical Performance Is Translational For Clinical Utility Of Cell-Free Tumor DNA Diagnostics 8/26/2014 9:13:03 AM
Clinical Results Presented For TrovaGene, Inc.'s Urine-Based High-Risk HPV Assay 8/25/2014 8:51:42 AM
Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins TrovaGene, Inc.'s Scientific Advisory Board 8/12/2014 9:19:45 AM
TrovaGene, Inc. Announces Second Quarter 2014 Financial Results 8/8/2014 8:06:14 AM
TrovaGene, Inc. Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call 7/30/2014 9:33:13 AM
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014 10:21:12 AM